# Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

> **NCT03533517** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Ancora Heart, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Heart Failure
- Cardiomyopathy, Dilated

## Interventions

- **DEVICE:** AccuCinch® Ventricular Restoration

## Key facts

- **NCT ID:** NCT03533517
- **Lead sponsor:** Ancora Heart, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-08-23
- **Primary completion:** 2021-03-26
- **Final completion:** 2026-02-28
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03533517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03533517, "Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03533517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*